XIAOMI-W
01810
POP MART
09992
BYD COMPANY
01211
4
TIANBAO ENERGY
01671
5
MEITUAN-W
03690
HK Stock MarketDetailed Quotes
06826 HAOHAI BIOTEC
- 24.550
- +0.100+0.41%
Not Open Apr 30 16:08 CST
5.72BMarket Cap12.79P/E (TTM)
24.650High24.200Low117.18KVolume24.400Open24.450Pre Close2.87MTurnover0.30%Turnover Ratio12.61P/E (Static)233.19MShares42.95052wk High0.93P/B960.93MFloat Cap21.70052wk Low1.24Dividend TTM39.14MShs Float104.586Historical High0.795Dividend LFY1.84%Amplitude13.033Historical Low24.525Avg Price100Lot Size5.04%Div YieldTTM3.24%Div Yield LFY
HAOHAI BIOTEC News
Haohai Biological Technology's Q1 Profit Slides 7%
HAOHAI BIOTEC (06826.HK) spent 1.67 million HKD to repurchase 0.07 million shares on April 28.
Gelonghui April 28丨HAOHAI BIOTEC (06826.HK) announced that on April 28, 1.67 million HKD was spent to repurchase 0.07 million shares.
HAOHAI BIOTEC (06826) spent 1.6695 million HKD on April 28 to repurchase 0.07 million shares.
HAOHAI BIOTEC (06826) announced that on April 28, 2025, it will spend 1.6695 million Hong Kong dollars to repurchase...
Shanghai Haohai Biological Technology (688366.SH) reported a Net income of 90.3121 million yuan in the first quarter, a decrease of 7.41% year-on-year.
Gelonghui reported on April 26 that Shanghai Haohai Biological Technology (688366.SH) released its quarterly report, achieving total operating revenue of 0.619 billion yuan in the first quarter of 2025, a year-on-year decrease of 4.25%; the Net income attributable to shareholders of the parent company was 90.3121 million yuan, down 7.41% year-on-year; the EPS was 0.39 yuan.
Shanghai Haohai Biotechnology Co., Ltd. Report for the first quarter of 2025
HAOHAI BIOTEC (06826) announced its first-quarter performance with a net profit attributable to the parent company of approximately 90.3121 million yuan, a decrease of 7.41% year-on-year.
HAOHAI BIOTEC (06826) announced its performance for the first quarter of 2025, with revenue of approximately 0.6185 billion yuan, same...
Express News | Shanghai Haohai Biological Technology - Qtrly Net Profit Attributable RMB90.3 Mln
HAOHAI BIOTEC: 2025 FIRST QUARTERLY REPORT
HAOHAI BIOTEC: ANNUAL REPORT 2024
HAOHAI BIOTEC (06826.HK) spent 8.648 million yuan to repurchase 0.16 million A shares on April 16.
On April 16, HAOHAI BIOTEC (06826.HK) announced that it spent 8.648 million yuan on April 16, 2025, to repurchase 0.16 million A shares, with a repurchase price per share ranging from 53.66 to 54.5 yuan.
HAOHAI BIOTEC (06826.HK) held a Board of Directors meeting on April 25 to review and approve the first quarter results.
Gelonghui announced on April 11 that HAOHAI BIOTEC (06826.HK) will hold a Board of Directors meeting on April 25, 2025 (Friday) to review and approve the quarterly results and its release for the three months ending March 31, 2025.
HAOHAI BIOTEC: DATE OF BOARD MEETING
HAOHAI BIOTEC (06826.HK) spent 15.2797 million yuan to repurchase 0.279 million A-shares on April 8.
On April 8, Gelonghui reported that HAOHAI BIOTEC (06826.HK) announced the repurchase of 279,000 A-shares for a total cost of 15.2797 million RMB on April 8, 2025, with the repurchase price ranging from 54.11 to 55 yuan per share.
HAOHAI BIOTEC (06826.HK) spent 11.5162 million yuan to repurchase 0.2203 million A-shares on April 7.
On April 7, Gelonghui reported that HAOHAI BIOTEC (06826.HK) announced the repurchase of 0.2203 million A-shares at a cost of 11.5162 million yuan on April 7, 2025, with a repurchase price ranging from 49.25 to 54.97 yuan per share.
Shanghai Haohai Biological Technology (688366.SH): A total of 0.8267 million shares of the company's A-shares have been repurchased.
Gelonghui, April 1 - Shanghai Haohai Biological Technology (688366.SH) announced that as of March 31, 2025, the company has cumulatively repurchased 0.8267 million A-shares through centralized bidding trading, accounting for 0.35% of the company's total share capital. The highest Fill Price was 63.58 yuan/share, the lowest Fill Price was 56.78 yuan/share, and the total amount reached 50.4938 million yuan (excluding stamp duty, trading commission, and other transaction fees).
HAOHAI BIOTEC (06826): Gan Renbao is no longer serving as the company's core technical personnel.
HAOHAI BIOTEC (06826) announced that Mr. Gan Renbao, a core technical personnel, will no longer serve due to advanced age...
Shanghai Haohai Biological Technology (HKG:6826) Sheds 6.4% This Week, as Yearly Returns Fall More in Line With Earnings Growth
Zhitong Hong Kong stock repurchase Statistics | March 26
Hong Kong stock repurchase Statistics | March 26th
HAOHAI BIOTEC (06826.HK) spent 0.5422 million HKD to repurchase 0.02 million shares on March 25.
On March 25, Gelonghui reported that HAOHAI BIOTEC (06826.HK) announced it spent 0.5422 million Hong Kong dollars to repurchase 0.02 million shares on March 25, 2025, with a repurchase price of 27.1-27.15 Hong Kong dollars per share.
Haohai Biological Technology's Profit Jumps 1% in 2024